Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
Q3 2023 vs. Q2 2023
How the institutions holding Third Harmonic Bio, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 48 | 56 | +8 |
| Shares | 36.1M | 37.8M | +1.73M (+4.8%) |
| Value | $173.5M | $241.5M | +$68.0M (+39.2%) |
New holders (11)
Institutions that held Third Harmonic Bio, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Braidwell LP | 1,653,991 | $10.6M | 0.33% |
| Ra Capital Management, L.P. | 961,863 | $6.15M | 0.12% |
| DAFNA Capital Management LLC | 300,000 | $1.92M | 0.60% |
| Atika Capital Management LLC | 203,199 | $1.30M | 0.18% |
| Adage Capital Partners GP, L.L.C. | 192,027 | $1.23M | 0.00% |
| UBS Oconnor LLC | 125,000 | $798.8K | 0.01% |
| Jacobs Levy Equity Management, Inc | 33,428 | $213.6K | 0.00% |
| MetLife Investment Management | 11,604 | $74.2K | 0.00% |
| Annapolis Financial Services, LLC | 5,000 | $31.9K | 0.01% |
| Metropolitan Life Insurance Co | 1,255 | $8.02K | 0.00% |
| Russell Investments Group, Ltd. | 320 | $2.04K | 0.00% |
Sold out (3)
Institutions that held Third Harmonic Bio, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Stonepine Capital Management, LLC | 2,793,149 | $13.4M |
| Bain Capital Life Sciences Investors, LLC | 640,631 | $3.08M |
| Goldman Sachs Group Inc | 16,460 | $79.2K |